MYO1E and non-small cell lung carcinoma: In summary, survival meta-analysis of RNA expression data from caBIG, GEO and TCGA repositories showed that patients with high expression of MYO1E had lower survival and increased risk of mortality for NSCLC (n = 1925) and LUAD (n = 719), but not for LUSC (n = 524).